ATE401912T1 - Methoden der zubereitung von immunglobulin und dessen verwendungen - Google Patents

Methoden der zubereitung von immunglobulin und dessen verwendungen

Info

Publication number
ATE401912T1
ATE401912T1 AT01971026T AT01971026T ATE401912T1 AT E401912 T1 ATE401912 T1 AT E401912T1 AT 01971026 T AT01971026 T AT 01971026T AT 01971026 T AT01971026 T AT 01971026T AT E401912 T1 ATE401912 T1 AT E401912T1
Authority
AT
Austria
Prior art keywords
methods
immunoglobulin
preparation
conditions
provides
Prior art date
Application number
AT01971026T
Other languages
English (en)
Inventor
William Pollack
Original Assignee
Atopix Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atopix Pharmaceuticals Corp filed Critical Atopix Pharmaceuticals Corp
Application granted granted Critical
Publication of ATE401912T1 publication Critical patent/ATE401912T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01971026T 2000-09-13 2001-09-13 Methoden der zubereitung von immunglobulin und dessen verwendungen ATE401912T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/660,862 US6962700B1 (en) 2000-09-13 2000-09-13 Method of manufacturing immune globulin

Publications (1)

Publication Number Publication Date
ATE401912T1 true ATE401912T1 (de) 2008-08-15

Family

ID=24651263

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01971026T ATE401912T1 (de) 2000-09-13 2001-09-13 Methoden der zubereitung von immunglobulin und dessen verwendungen

Country Status (6)

Country Link
US (2) US6962700B1 (de)
EP (1) EP1320351B1 (de)
AT (1) ATE401912T1 (de)
AU (1) AU2001290962A1 (de)
DE (1) DE60134993D1 (de)
WO (1) WO2002022079A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1614693A4 (de) * 2003-03-31 2006-07-19 Kirin Brewery Reinigung eines humanen monoklonalen antikörpers und humanen polyklonalen antikörpers
EP1799813B1 (de) * 2004-10-13 2010-05-19 Metabogal Ltd. System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
RU2009148891A (ru) 2007-06-01 2011-07-20 Ф.Хоффманн-Ля Рош Аг (Ch) Очистка иммуноглобулина
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10232048B1 (en) 2014-11-18 2019-03-19 Divine Api-Logics, LLC Apitherapy method and composition
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US20220324961A1 (en) * 2021-04-12 2022-10-13 IgGenix, Inc. Allergy therapy
EP4444348A4 (de) * 2021-12-08 2025-12-03 Iggenix Inc Kombinationen für allergietherapie

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089944A (en) * 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
DE2837168A1 (de) 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
JPS57206608A (en) 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4482483A (en) 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4719290A (en) 1983-09-02 1988-01-12 Armour Pharmaceutical Corporation Composition of intravenous immune globulin
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
JPS61286754A (ja) 1985-06-12 1986-12-17 Shionogi & Co Ltd モノクロ−ナル抗ヒトＩｇＧ↓４抗体およびその製造法
US5346687A (en) * 1989-08-09 1994-09-13 Rhomed Incorporated Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
US5177194A (en) 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
CA2078805C (en) 1992-09-22 1997-02-25 Intelcor Biotech Enterprises Inc. Cytokine preparation
US5489519A (en) * 1992-10-27 1996-02-06 Queen's University At Kingston Multidrug resistance protein
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
US6165981A (en) * 1995-03-07 2000-12-26 Dade Behring Inc. Stabilizing solutions for proteins and peptides
ES2421736T3 (es) * 1998-06-09 2013-09-05 Csl Behring Ag Procedimiento para la preparación de inmunoglobulinas para administración intravenosa y otros productos inmunoglobulínicos

Also Published As

Publication number Publication date
US20020064526A1 (en) 2002-05-30
US6962700B1 (en) 2005-11-08
AU2001290962A1 (en) 2002-03-26
DE60134993D1 (de) 2008-09-04
US7276236B2 (en) 2007-10-02
EP1320351B1 (de) 2008-07-23
EP1320351A2 (de) 2003-06-25
WO2002022079A2 (en) 2002-03-21
EP1320351A4 (de) 2004-07-28
WO2002022079A3 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
DK0703922T3 (da) Fremgangsmåde til fremstilling af immunoglobulin G koncentrat
ATE419009T1 (de) Methoden und zusammensetzungen bestehend aus glykoprotein-glykoformen
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DE60229059D1 (de) Proteomimetische verbindungen und verfahren
MX9602971A (es) Anticuerpos humanizados contra la molecula vla-4 de adhesion de leucocitos.
GEP20227392B (en) Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
DE60328747D1 (de) Reinigung von polyreaktiven Autoantikörpern und deren Verwendungen
ATE401912T1 (de) Methoden der zubereitung von immunglobulin und dessen verwendungen
ATE151078T1 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
MX2023009447A (es) Anticuerpos que se unen a metapneumovirus, proteínas antigénicas de metapneumovirus, y usos de los mismos.
ATE540694T1 (de) Verfahren zur behandlung der thrombozytopenie mit monoklonalem ivig
ATE343398T1 (de) Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge
ATE425187T1 (de) Materialien und methoden zur behandlung von hepatitis c
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE69029858D1 (de) Behandlung von einer autoimmun-krankheit
ZA202211253B (en) Compositions comprising 15-hepe for treating or preventing hematologic disorders, and/or related diseases
MX2024005962A (es) Composiciones de proteínas de fusión inmunogénicas y métodos de uso de estas
EA202191220A1 (ru) НОВЫЕ МОЧЕВИНО-6,7-ДИГИДРО-4H-ПИРАЗОЛО[4,3-с]ПИРИДИНЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА В (HBV)
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer
MXPA03010829A (es) Uso de inmunoglobulinas policlonales.
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
CR20250130A (es) Anticuerpos anti-lair1 humano
DE60041266D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE60223571D1 (de) Verbindungen vom pyrroltyp, zusammensetzungen und verfahren zur behandlung von krebs, zur behandlung von virenerkrankungen und zur unterdrückung der immunreaktion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties